Table 3.
Univariate analysis | |||||
---|---|---|---|---|---|
HR | 95% CI | P value | |||
Clinical features | Sex | 1.30 | 0.69 | 2.40 | 0.421 |
Age less than 65 years | 2.60 | 1.20 | 5.40 | 0.012* | |
Primary tumor location | |||||
Rectum | 1.30 | 0.53 | 3.00 | 0.598 | |
Right colon | 1.40 | 0.64 | 2.90 | 0.426 | |
Pathologic stage | |||||
Stage I | 0.11 | 0.02 | 0.59 | 0.010* | |
Stage II | 0.24 | 0.08 | 0.76 | 0.015* | |
Stage III | 0.56 | 0.19 | 1.70 | 0.301 | |
Stage IV | 0.39 | 0.10 | 1.60 | 0.189 | |
Candidate genes | ALG8 | 0.017 | 0.0017 | 0.17 | <0.0001*** |
SRD5A3 | 0.19 | 0.04 | 0.92 | 0.040* | |
ALG6 | 0.03 | 0.0023 | 0.39 | 0.007** | |
STT3B | 0.07 | 0.0095 | 0.52 | 0.009** | |
GALNT3 | 0.21 | 0.058 | 0.75 | 0.016* | |
B3GNT6 | 0.48 | 0.32 | 0.72 | <0.001*** | |
GALNT8 | 0.47 | 0.27 | 0.82 | 0.008** |
HR, hazard ratio.
*P < 0.05, **P < 0.01, ***P < 0.001.